Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$8.11 USD
-0.40 (-4.70%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $8.09 -0.02 (-0.25%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.67 |
EPS Last Quarter | -0.61 |
Last EPS Surprise | 10.29% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.61 |
Next Year | -2.73 |
EPS (TTM) | -3.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 8.09M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.67 | -0.68 | -2.61 | -2.73 |
# of Estimates | 6 | 6 | 8 | 7 |
Most Recent Consensus | -0.69 | -0.71 | -2.54 | -2.08 |
High Estimate | -0.63 | -0.63 | -2.53 | -2.08 |
Low Estimate | -0.70 | -0.73 | -2.72 | -3.49 |
Year ago EPS | -1.05 | -1.00 | -4.83 | -2.61 |
Year over Year Growth Est. | 36.19% | 32.00% | 45.96% | -4.50% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 5 | 5 | 6 | 4 |
Up Last 60 Days | 4 | 4 | 5 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 60 Days | 2 | 2 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.67 | -0.68 | -2.61 | -2.73 |
7 Days Ago | -0.67 | -0.68 | -2.61 | -2.73 |
30 Days Ago | -0.71 | -0.70 | -2.71 | -2.78 |
60 Days Ago | -0.68 | -0.67 | -2.64 | -2.60 |
90 Days Ago | -0.69 | -0.69 | -2.65 | -2.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.68 | -2.61 | -2.73 |
Zacks Consensus Estimate | -0.67 | -0.68 | -2.61 | -2.73 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.61 | -0.64 | -1.00 | -1.05 | NA |
Estimate | -0.68 | -0.57 | -1.01 | -1.20 | NA |
Difference | 0.07 | -0.07 | 0.01 | 0.15 | 0.04 |
Surprise | 10.29% | -12.28% | 0.99% | 12.50% | 2.88% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more